Declining Differences in Response Rates with Antidepressants versus Placebo
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference17 articles.
1. Vilazodone for major depressive disorder.;Kalia;Curr Psychiatry,2011
2. CNS drug development. Part I: The early period of CNS drugs.;Preskorn;J Psychiatr Pract,2010
3. CNS drug development: Part II: Advances from the 1960s to the 1990s.;Preskorn;J Psychiatr Pract,2010
4. CNS drug development: Part III: Future directions.;Preskorn;J Psychiatr Pract,2011
5. Evidence of the dual mechanisms of action of venlafaxine.;Harvey;Arch Gen Psychiatry,2000
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy;Wiener klinische Wochenschrift;2024-04-17
2. Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a systematic review and meta-analysis of randomised, placebo-controlled trials;BMJ Mental Health;2024-01
3. Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials;Archives of Women's Mental Health;2022-01-01
4. The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder;Depression and Anxiety;2021-07-22
5. Consistency of the Antidepressant Effect of Intranasal Esketamine in Phase 3 Clinical Trials;Journal of Psychiatric Practice;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3